- Home
- WALD vs TERN Comparison
WALD vs TERN Comparison
Compare WALD & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- TERN
- Stock Information
- Founded
- WALD 1988
- TERN 2017
- Country
- WALD United Kingdom
- TERN United States
- Employees
- WALD N/A
- TERN N/A
- Industry
- WALD Package Goods/Cosmetics
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- WALD Consumer Discretionary
- TERN Health Care
- Exchange
- WALD Nasdaq
- TERN Nasdaq
- Market Cap
- WALD 404.2M
- TERN 382.2M
- IPO Year
- WALD 2021
- TERN 2021
- Fundamental
- Price
- WALD $3.03
- TERN $4.45
- Analyst Decision
- WALD Strong Buy
- TERN Buy
- Analyst Count
- WALD 4
- TERN 5
- Target Price
- WALD $5.95
- TERN $18.30
- AVG Volume (30 Days)
- WALD 82.7K
- TERN 1.8M
- Earning Date
- WALD 08-27-2024
- TERN 03-13-2025
- Dividend Yield
- WALD N/A
- TERN N/A
- EPS Growth
- WALD N/A
- TERN N/A
- EPS
- WALD N/A
- TERN N/A
- Revenue
- WALD $240,382,000.00
- TERN N/A
- Revenue This Year
- WALD $27.29
- TERN N/A
- Revenue Next Year
- WALD $19.54
- TERN N/A
- P/E Ratio
- WALD N/A
- TERN N/A
- Revenue Growth
- WALD N/A
- TERN N/A
- 52 Week Low
- WALD $2.41
- TERN $4.32
- 52 Week High
- WALD $9.46
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- WALD 37.47
- TERN 27.09
- Support Level
- WALD $2.96
- TERN $4.38
- Resistance Level
- WALD $3.15
- TERN $5.95
- Average True Range (ATR)
- WALD 0.21
- TERN 0.29
- MACD
- WALD -0.06
- TERN -0.09
- Stochastic Oscillator
- WALD 23.57
- TERN 4.46
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It is organized into two reportable segments namely Obagi Skincare and Milk Makeup.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.